Calidad de vida relacionada con la salud e intervenciones emergentes en EPOC: revisión de literatura

Palabras clave: Enfermedad Pulmonar Obstructiva Crónica, Calidad de Vida., Calidad de Vida Relacionada con la Salud, Disnea, Autocuidado

Resumen

La enfermedad pulmonar obstructiva crónica (EPOC) es una enfermedad con amplias implicaciones sociales y económicas, su incidencia mundial seguirá aumentando, siendo para la próxima década la cuarta causa global de muerte. El deterioro físico subsecuente a la disfunción pulmonar, trae consigo cambios multisistémicos que desencadenan la reducción de la capacidad funcional del individuo, dichos fenómenos están relacionados con la severidad de los síntomas y también el nivel detrimento del sistema cardiovascular y musculoesquelético. Por ende, los pacientes con EPOC tienden a reducir su calidad de vida relacionada con la salud (CVRS) y consigo, una reducción de la expectativa de vida. El tratamiento del paciente con esta enfermedad no se limita a la farmacoterapia y tratamientos paliativos secundarios, sino que también trasciende en la identificación e intervención de factores que afectan la CVRS. La presente revisión tuvo los objetivos de explorar, analizar y exponer evidencia científica conspicua que asocia a la funcionalidad y CVRS en pacientes con EPOC. Los hallazgos muestran la importancia de evaluar e intervenir los factores que reducen la CVRS. Alternativas como la educación y coaching en salud parecen lograr reducir el impacto de la enfermedad en diversas esferas del individuo.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Roberto Carlos Rebolledo-Cobos, Universidad Metropolitana

Universidad Metropolitana, Programa de Fisioterapia. Barranquilla, Colombia.

Julieta Vera-Brand, Universidad Simón Bolívar

Universidad Simón Bolívar, Facultad de Ciencias de la Salud. Barranquilla, Colombia.

Cruz María Ahumada-Sánchez, Universidad Simón Bolívar

 Especialización en Adaptación y Rehabilitación Cardiopulmonar y Vascular. Barranquilla, Colombia

Luisa Hernández-Flores, Universidad Simón Bolívar

Especialización en Adaptación y Rehabilitación Cardiopulmonar y Vascular. Barranquilla, Colombia

Aura Ruiz-Campillo, Universidad Simón Bolívar

Universidad Simón Bolívar, Especialización en Adaptación y Rehabilitación Cardiopulmonar y Vascular. Barranquilla, Colombia.

Referencias bibliográficas

Halpin D, Celli B, Criner G, Frith P, López M, Salvi S, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019; 23(11):1131-41. Doi: 10.5588/ijtld.19.0397

GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disabilityadjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. Doi: 10.1016/S2213-2600(17)30293-X

Singh D, Agusti A, Anzueto A, Barnes P, Bourbeau J, Bartolome R, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. Doi: 10.1183/13993003.00164-2019

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D, et al. International variation in the prevalence of COPD (The BOLD Study): a populationbased prevalence study. Lancet. 2007; 370:741-50. Doi: 10.1016/S0140-6736(07)61377-4

Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren L, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015; 148(4):971-85. Doi: 10.1378/chest.14-2535

Ntritsos G, Franek J, Belbasis L, Christou M, Markozannes G, Altman P, et al. Gender-specific estimates of COPD prevalence:a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018; 10(13):1507-14. Doi: 10.2147/COPD.S146390

Perez-Padilla R, Menezes A. Chronic Obstructive Pulmonary Disease in Latin America. Ann Glob Health. 2019; 85(1):7. Doi: 10.5334/aogh.2418

Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008; 3(2):343-9. Doi: 10.1378/chest.07-1361

Gil Rojas Y, Torres Duque CA, Figueredo M del C, Hernández F, Castañeda Cardona C, Lasalvia P, Rosselli D. Estimación de la prevalencia de EPOC en Colombia a partir del Registro Individual de Prestaciones de Servicios de Salud (RIPS). Rev Colomb Neumol. 2019; 31(1)

Patel J, Coutinho A, Lunacsek O, Dalal A. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018; 13(1):2301-11. Doi: 10.2147/COPD.S163795

Chapel J, Ritchey M, Zhang D, Wang G. Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries. Am J Prev Med. 2017; 53(6S2): S143-54. Doi: 10.1016/j.amepre.2017.07.019

Vinaccia S, Quiceno J. Calidad de Vida Relacionada con la Salud y Factores Psicológicos: Un Estudio desde la Enfermedad Pulmonar Obstructiva Crónica – EPOC. Terapia Psicológica. 2011; 29(1):65-75. Doi: http://dx.Doi.org/10.4067/S0718-48082011000100007

Cappa V, Marcon A, Di Gennaro G, Chamitava L, Cazzoletti L, Bombieri C, et al. Health-related quality of life varies in different respiratory disorders: a multicase control population-based study. BMC Pulm Med. 2019;19(1):32. Doi: 10.1186/s12890-019-0796-8

McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;10(2):CD003793. Doi: 10.1002/14651858.CD003793.pub3

McDonald CF. ACP Journal Club. Review: Pulmonary rehabilitation improves health-related QoL and exercise apacity more than usual care in COPD. Ann Intern Med. 2015;162(12): JC4. Doi: 10.7326/ACPJC-2015-162-12-004

Meshe O, Claydon L, Bungay H, Andrew S. The relationship between physical activity and health status in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation. Disabil Rehabil. 2017;39(8):746-56. Doi: 10.3109/09638288.2016.1161842

Hettle R, Wouters H, Ayres J, Gani Y, Kelly S, Lion M, et al. Cost-Utility Analysis of Tiotropium Versus Usual Care In Patients With Copd In The Uk And Belgium. Respir Med. 2012; 106(12):1722-33. Doi: 10.1016/j.rmed.2012.09.006

García Olmos L, Alberquilla A, Ayala V, García Sagredo P, Morales L, Montserrat Carmona M, Et Al. Comorbidity In Patients With Chronic Obstructive Pulmonary Disease In Family Practice: A Cross Sectional Study. Bmc Family Practice. 2013; 14:11. Doi: 10.1186/1471-2296-14-11

Mittal R, Chhabra SK. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment. COPD. 2017; 14(1):1-6. Doi: 10.1080/15412555.2016.1230844

Sidhaye V, Nishida K, Martinez F. Precision medicine in COPD: where are we and where do we need to go?. Eur Respir Rev. 2018;27(149):180022. Doi: 10.1183/16000617.0022-2018

Gonçalves I, Guimarães M, van Zeller M, Menezes F, Moita J, Simão P. Clinical and molecular markers in COPD. Pulmonology. 2018; 24(4):250-259. Doi: 10.1016/j.pulmoe.2018.02.005

Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, et al. Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease. Respiration. 2017; 93(1):32-41. Doi: 10.1159/000452479

Singh D, Long G, Cançado JED, Higham A. Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician. Curr Opin Pulm Med. 2020; 26(2):162-168. Doi: 10.1097/MCP.0000000000000637

Higham A, Quinn A, Cançado J, Singh D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 2019; 20(1):49. Doi: https://Doi.org/10.1186/s12931-019-1017-y

Martin C, Frija J, Burgel P. Dysfunctional lung anatomy and small airways degeneration in COPD. Int J Chron Obstruct Pulmon Dis. 2013; 8:7-13. Doi: 10.2147/COPD.S28290

Balbi B, Sangiorgi C, Gnemmi I, Ferrarotti I, Vallese D, Paracchini E, et al. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1879-93. Doi: 10.2147/COPD.S207203

Bradford E, Jacobson S, Varasteh J, Comellas AP, Woodruff P, O’Neal W, et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017; 18(1):180. Doi: 10.1186/s12931-017-0662-2

Riley C, Sciurba F. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review. JAMA. 2019; 321(8):786-797. Doi: 10.1001/jama.2019.0131

Dubé BP, Vermeulen F, Laveneziana P. Exertional Dyspnoea in Chronic Respiratory Diseases: From Physiology to Clinical Application. Arch Bronconeumol. 2017; 53(2):62-70. Doi: 10.1016/j.arbr.2016.11.003

Rebolledo-Cobos R, Teixeira B, Correa C. Asthma, physical exercise and oxidative stress: a review of literature. Fisioterapia. 2014;36(1):40-8. Doi:10.1016/j.ft.2013.06.002

Ijiri N, Kanazawa H, Yoshikawa T, Hirata K. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014; 9:1235-40. Doi: 10.2147/COPD.S71383

Leung J, Sin D. Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017; 358: j3772. Doi: 10.1136/bmj.j3772

Vermylen J, Szmuilowicz E, Kalhan R. Palliative care in COPD: an unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis. 2015; 10:1543-51. Doi: 10.2147/COPD.S74641

Waters A. How do you assess quality of life? Vet Rec. 2018; 183(22):671. Doi: 10.1136/vr.k5169.

Karimi M, Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?Pharmacoeconomics. 2016; 34(7):645-9. Doi: 10.1007/s40273-016-0389-9

Brien S, Stuart B, Dickens A, Kendrick T, Jordan R, Adab P, et al. Independent determinants of disease-related quality of life in COPD - scope for nonpharmacologic interventions?. Int J Chron Obstruct Pulmon Dis. 2018; 13:247-56. Doi: 10.2147/COPD.S152955

Esquinas C, Ramon M, Nuñez A, Molina J, Quintano J, Roman-Rodríguez M, et al. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res. 2020; 29(3):607-17. Doi: 10.1007/s11136-019-02340-4

Calzetta L, Matera M, Braido F, Contoli M, Corsico A, Di Marco F, et al. Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. Pulm Pharmacol Ther. 2017; 45:148-58. Doi: 10.1016/j.pupt.2017.06.002

Rugbjerg M, Iepsen U, Jørgensen K, Lange P. Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with metaanalyses. Int J Chron Obstruct Pulmon Dis. 2015; 10:791-801. Doi: 10.2147/COPD.S78607

Bellou V, Belbasis L, Konstantinidis A, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019; 367:l5358. Doi: https://Doi.org/10.1136/bmj.l5358

Bringsvor H, Langeland E, Oftedal B, Skaug K, Assmus J, Bentsen S. Self-management and health related quality of life in persons with chronic obstructive pulmonary disease. Qual Life Res. 2019; 28(11):2889-99. Doi: 10.1007/s11136-019-02231-8

Tiemensma J, Gaab E, Voorhaar M, Asijee G, Kaptein A. Illness perceptions and coping determine quality of life in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016; 11:2001-7. Doi: 10.2147/COPD.S109227

Weldam S, Lammers J, Heijmans M, Schuurmans M. Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract. 2014; 15:140. Doi: 10.1186/1471-2296-15-140

Cannon D, Sriram K, Liew A, Sun J. Resilience Factors Important in Health-Related Quality of Life of Subjects With COPD. Respir Care. 2018; 63(10):1281-92. Doi: 10.4187/respcare.05935

Benzo R, Vickers K, Novotny P, Tucker S, Hoult J, Neuenfeldt P, et al. Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. Am J Respir Crit Care Med. 2016; 194(6):672-80. Doi: 10.1164/rccm.201512-2503OC

Tupper O, Gregersen T, Ringbaek T, Brøndum E, Frausing E, Green A, et al. Effect of tele-health care on quality of life in patients with severe COPD:a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:2657. Doi: 10.2147/COPD.S164121

Vianello A, Fusello M, Gubian L, Rinaldo C, Dario C, Concas A, et al.Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2016; 16(1):157. Doi: 10.1186/s12890-016-0321-2

Stamenova V, Liang K, Yang R, Engel K, van Lieshout F, Lalingo E, et al. Technology-Enabled Self-Management of Chronic Obstructive Pulmonary Disease With or Without Asynchronous Remote Monitoring: Randomized Controlled Trial. J Med Internet Res. 2020; 22(7):e18598. Doi: 10.2196/18598

Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim S, Saunders J, et al. Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease:A Randomized Clinical Trial. JAMA. 2019; 322(14):1371-80. Doi: 10.1001/jama.2019.11982

Ringbæk T, Green A, Laursen L, Frausing E, Brøndum E, Ulrik C. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease:a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2015; 10:1801-8. Doi: 10.2147/COPD.S85596

Cómo citar
(1)
Rebolledo-Cobos, R. C.; Vera-Brand, J.; Ahumada-Sánchez, C. M.; Hernández-Flores, L.; Ruiz-Campillo, A. Calidad De Vida Relacionada Con La Salud E Intervenciones Emergentes En EPOC: Revisión De Literatura. Rev. Fac. Cienc. Salud Univ. Cauca 2021, 23, 27-38.
Publicado
2021-11-22

Datos de financiación

Más sobre este tema